Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Non Operating Income (2016 - 2025)

Historic Non Operating Income for STRATA Skin Sciences (SSKN) over the last 13 years, with Q3 2025 value amounting to -$449000.0.

  • STRATA Skin Sciences' Non Operating Income rose 426.44% to -$449000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year decrease of 5616.3%. This contributed to the annual value of -$1.0 million for FY2024, which is 5681.62% up from last year.
  • According to the latest figures from Q3 2025, STRATA Skin Sciences' Non Operating Income is -$449000.0, which was up 426.44% from -$265000.0 recorded in Q2 2025.
  • STRATA Skin Sciences' Non Operating Income's 5-year high stood at $2.0 million during Q2 2021, with a 5-year trough of -$1.2 million in Q2 2023.
  • In the last 5 years, STRATA Skin Sciences' Non Operating Income had a median value of -$249000.0 in 2023 and averaged -$187210.5.
  • Within the past 5 years, the most significant YoY rise in STRATA Skin Sciences' Non Operating Income was 1126111.11% (2021), while the steepest drop was 230000.0% (2021).
  • Quarter analysis of 5 years shows STRATA Skin Sciences' Non Operating Income stood at -$205000.0 in 2021, then fell by 12.68% to -$231000.0 in 2022, then tumbled by 92.64% to -$445000.0 in 2023, then grew by 1.12% to -$440000.0 in 2024, then decreased by 2.05% to -$449000.0 in 2025.
  • Its Non Operating Income was -$449000.0 in Q3 2025, compared to -$265000.0 in Q2 2025 and -$417000.0 in Q1 2025.